Friday, 16 October 2026
USUnited States
INIndiaNSE and BSE IPOs, GMP, stocksUSUnited StatesSEC IPO filings, Treasury yields, FedEUEuropeIPOs, ECB rates, euro exchange rates
Xflot
AboutDaily briefsContact Search
Business TodayUS IPO calendarNew SEC filingsTreasury & FedNasdaqNYSEAI
Brent rises to $101.50 as a Gulf of Mexico storm threatens 15% of US crude output and fighting flares in YemenApplied Digital's quarterly revenue quadruples to $341.9 million; data-centre leases reach 1.41 GW and about $36 billionMicrosoft opens orders for a $2,599 Surface Laptop Ultra on Nvidia's RTX Spark chip and moves Copilot onto the PCAnthropic launches Claude Haiku 5.5 at $0.10 per million input tokens, 90% below Haiku 4.5 for shorter requestsWebull falls 19% after a House panel says its ownership, staff and technology are tied to ChinaDow drops 341 points as the US 10-year yield reaches 5.36%, a 24-year high; S&P 500 and Nasdaq slip 0.2% from recordsFed minutes: most officials saw one more rate increase by year-end; they split on why they raised in SeptemberMicron's Taoyuan union wins a 99% strike mandate in a bonus dispute; shares slip over 2% before the bellChevron hands its Hess Midstream stake and DJ Basin pipelines to Hess Midstream; books a $3-4 billion lossFrasers Group discloses an 8.8% stake in Under Armour, about 16.6 million shares worth roughly $80 million
Fed funds (effective) 3.88%US 2-year 4.77%US 10-year 5.10%Official rates →

United States · IPO calendar

Apnimed, Inc. IPO

listed

ExchangeNasdaq
TickerAPMD
Price range$14–16
IPO price$16
Deal size$192m
First-day close$25 (+56.3%)
First trading day31 Jul 2026
IndustryHealth Care
HeadquartersUnited States

Upsized to 12 million shares from 10 million; priced at the high end of the $14-$16 range. Sleep apnea drug developer. Source does not say if size includes over-allotment.

Deal terms: Renaissance Capital ↗

This page reports public filings and reported deal terms. It is not a recommendation to buy, sell or apply.

Free · one email a day

Market briefs, by country

Pick the markets you follow. Each morning: what changed, in figures — never a tip.

Markets

Free. We email a link to confirm — nothing is sent until you click it. Every brief has a one-click unsubscribe that deletes your record. Data, not advice: XDQ Labs is not registered with SEBI, the US SEC, FINRA or any European regulator. GMP is unofficial. Privacy. Sent daily at 08:15 India time.